Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo

doi:10.1084/jem.172.1.77

This Article

	Full Text (PDF, 810K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Kovach, N. L.
	Articles by Harlan, J. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Kovach, N. L.
	Articles by Harlan, J. M.


Social Bookmarking

	What's this?

ARTICLES

Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo

NL Kovach, E Yee, RS Munford, CR Raetz and JM Harlan
Department of Medicine, University of Washington, Harborview Medical Center, Seattle 98104.

Tumor necrosis factor (TNF) released by lipopolysaccharide (LPS)- stimulated mononuclear phagocytes is a critical mediator of sepsis. We examined the capacities of rough mutant Salmonella typhimurium LPS (Rc) and LPS partial structures lipid A, monophosphoryl lipid A (MPLA), lipid IVA, and lipid X to induce production of TNF in whole blood. Rc LPS (0.0001-10 ng/ml) produced a dose-dependent release of TNF as determined by cytotoxicity of actinomycin D-sensitized L929 murine fibroblasts. Lipid A, MPLA, lipid IVA, and lipid X exhibited decreasing capacities to stimulate production of TNF in whole blood, respectively. Fractional deacylation of LPS by incubation with acyloxyacyl hydrolase isolated from human leukocytes produced a reduction in the capacity of LPS to induce TNF release in whole blood. Maximal enzymatic deacylation reduced activity of LPS by greater than 100-fold. Coincubation with lipid IVA inhibited TNF release induced by Rc LPS or lipid A, but not by phorbol ester. In contrast, MPLA, lipid X, and deacylated LPS failed to inhibit LPS-stimulated release of TNF. Corresponding to the inhibition of the release of TNF protein, lipid IVA also inhibited the accumulation of TNF mRNA in LPS-stimulated mononuclear cells. These results suggest that lipid IVA may act as a competitive antagonist of LPS, perhaps at the receptor level.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Rallabhandi, P., Awomoyi, A., Thomas, K. E., Phalipon, A., Fujimoto, Y., Fukase, K., Kusumoto, S., Qureshi, N., Sztein, M. B., Vogel, S. N. (2008). Differential Activation of Human TLR4 by Escherichia coli and Shigella flexneri 2a Lipopolysaccharide: Combined Effects of Lipid A Acylation State and TLR4 Polymorphisms on Signaling. J. Immunol. 180: 1139-1147 [Abstract] [Full Text]
Lohmann, K. L., Vandenplas, M. L., Barton, M. H., Bryant, C. E., Moore, J. N. (2007). The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist. Innate Immunity 13: 235-242 [Abstract]
Marques, J. M., Rodrigues, R. J., de Magalhaes-Sant'Ana, A. C., Goncalves, T. (2006). Saccharomyces cerevisiae Hog1 Protein Phosphorylation upon Exposure to Bacterial Endotoxin. J. Biol. Chem. 281: 24687-24694 [Abstract] [Full Text]
Cole, L. E., Elkins, K. L., Michalek, S. M., Qureshi, N., Eaton, L. J., Rallabhandi, P., Cuesta, N., Vogel, S. N. (2006). Immunologic Consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the Innate Immune Response in Infection and Immunity.. J. Immunol. 176: 6888-6899 [Abstract] [Full Text]
Wurfel, M. M., Park, W. Y., Radella, F., Ruzinski, J., Sandstrom, A., Strout, J., Bumgarner, R. E., Martin, T. R. (2005). Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity. J. Immunol. 175: 2570-2578 [Abstract] [Full Text]
Mueller, M., Brandenburg, K., Dedrick, R., Schromm, A. B., Seydel, U. (2005). Phospholipids Inhibit Lipopolysaccharide (LPS)-Induced Cell Activation: A Role for LPS-Binding Protein. J. Immunol. 174: 1091-1096 [Abstract] [Full Text]
Kawahara, K., Tsukano, H., Watanabe, H., Lindner, B., Matsuura, M. (2002). Modification of the Structure and Activity of Lipid A in Yersinia pestis Lipopolysaccharide by Growth Temperature. Infect. Immun. 70: 4092-4098 [Abstract] [Full Text]
Kaplan, R., Gan, X., Menke, J. G., Wright, S. D., Cai, T.-Q. (2002). Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway. J. Lipid Res. 43: 952-959 [Abstract] [Full Text]
Ingalls, R. R., Lien, E., Golenbock, D. T. (2001). Membrane-Associated Proteins of a Lipopolysaccharide-Deficient Mutant of Neisseria meningitidis Activate the Inflammatory Response through Toll-Like Receptor 2. Infect. Immun. 69: 2230-2236 [Abstract] [Full Text]
Zahringer, U., Salvetzki, R., Wagner, F., Lindner, B., Ulmer, A. J. (2001). Structural and biological characterisation of a novel tetra-acyl lipid A from Escherichia coli F515 lipopolysaccharide acting as endotoxin antagonist in human monocytes. Innate Immunity 7: 133-146 [Abstract]
Means, T. K., Jones, B. W., Schromm, A. B., Shurtleff, B. A., Smith, J. A., Keane, J., Golenbock, D. T., Vogel, S. N., Fenton, M. J. (2001). Differential Effects of a Toll-Like Receptor Antagonist on Mycobacterium tuberculosis-Induced Macrophage Responses. J. Immunol. 166: 4074-4082 [Abstract] [Full Text]
Haziot, A., Hijiya, N., Gangloff, S. C., Silver, J., Goyert, S. M. (2001). Induction of a Novel Mechanism of Accelerated Bacterial Clearance by Lipopolysaccharide in CD14-Deficient and Toll-Like Receptor 4-Deficient Mice. J. Immunol. 166: 1075-1078 [Abstract] [Full Text]
Plotz, S. G., Lentschat, A., Behrendt, H., Plotz, W., Hamann, L., Ring, J., Rietschel, E. Th., Flad, H.-D., Ulmer, A. J. (2001). The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood 97: 235-241 [Abstract] [Full Text]
Tanamoto, K.-i., Azumi, S. (2000). Salmonella-Type Heptaacylated Lipid A Is Inactive and Acts as an Antagonist of Lipopolysaccharide Action on Human Line Cells. J. Immunol. 164: 3149-3156 [Abstract] [Full Text]
Matsuura, M., Kiso, M., Hasegawa, A. (1999). Activity of Monosaccharide Lipid A Analogues in Human Monocytic Cells as Agonists or Antagonists of Bacterial Lipopolysaccharide. Infect. Immun. 67: 6286-6292 [Abstract] [Full Text]
Ingalls, R. R., Monks, B. G., Golenbock, D. T. (1999). Surface presentation of LPS is sufficient for initiation of signaling events. Innate Immunity 5: 244-248 [Abstract]
Tanamoto, K.-I. (1999). Induction of Lethal Shock and Tolerance by Porphyromonas gingivalis Lipopolysaccharide in D-Galactosamine-Sensitized C3H/HeJ Mice. Infect. Immun. 67: 3399-3402 [Abstract] [Full Text]
Ingalls, R. R., Monks, B. G., Golenbock, D. T. (1999). Membrane Expression of Soluble Endotoxin-binding Proteins Permits Lipopolysaccharide Signaling in Chinese Hamster Ovary Fibroblasts Independently of CD14. J. Biol. Chem. 274: 13993-13998 [Abstract] [Full Text]
Ingalls, R. R., Monks, B. G., Savedra, R. Jr., Christ, W. J., Delude, R. L., Medvedev, A. E., Espevik, T., Golenbock, D. T. (1998). CD11/CD18 and CD14 Share a Common Lipid A Signaling Pathway. J. Immunol. 161: 5413-5420 [Abstract] [Full Text]
Kobayashi, S., Kawata, T., Kimura, A., Miyamoto, K., Katayama, K., Yamatsu, I., Rossignol, D. P., Christ, W. J., Kishi, Y. (1998). Suppression of Murine Endotoxin Response by E5531, a Novel Synthetic Lipid A Antagonist. Antimicrob. Agents Chemother. 42: 2824-2829 [Abstract] [Full Text]
Cody, M.J., Salkowski, C.A., Henricson, B.E., Detore, G.R., Munford, R.S., Vogel, S.N. (1997). Effect of inflammatory and antiinflammatory stimuli on acyloxyacyl hydrolase gene expression and enzymatic activity in murine macrophages. Innate Immunity 4: 371-379 [Abstract]
Kitchens, R. L., Munford, R. S. (1995). Enzymatically Deacylated Lipopolysaccharide (LPS) Can Antagonize LPS at Multiple Sites in the LPS Recognition Pathway. J. Biol. Chem. 270: 9904-9910 [Abstract] [Full Text]
Schonbeck, U., Flad, H.-D., Rietschel, E. Th., Brandt, E., Loppnow, H. (1994). S-form LPS induces leukocyte adhesion to human vascular endothelial cells as potent as IL-1: lipid A precursor Ia antagonizes induction of adhesion by LPS. Innate Immunity 1: 4-13 [Abstract]
Heine, H., Brade, H., Kusumoto, S., Kusama, T., Rietschel, E. Th., Flad, H.-D., Ulmer, A.J. (1994). Inhibition of LPS binding on human monocytes by phosphonooxyethyl analogs of lipid A. Innate Immunity 1: 14-20 [Abstract]
Lien, E., Chow, J. C., Hawkins, L. D., McGuinness, P. D., Miyake, K., Espevik, T., Gusovsky, F., Golenbock, D. T. (2001). A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway. J. Biol. Chem. 276: 1873-1880 [Abstract] [Full Text]